Centessa Pharmaceuticals (NASDAQ:CNTA) Research Coverage Started at Wolfe Research
Wolfe Research assumed coverage on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) in a research report report published on Tuesday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $40.00 target price on the stock. Other research analysts have also recently issued research reports about the stock. Stephens assumed coverage on shares […]
27 Feb 06:13 · The Markets Daily